SGMT
SGMT
US7867001049
Sagimet Biosciences Inc. - Seri
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
56.889.000 54.454.000
4.5%
Operating Income -56.889.000 -54.454.000
4.5%
Pretax Income -51.038.000 -45.567.000
12.0%
Net Income Common Stockholders -51.038.000 -45.567.000
12.0%
-- --
--
-- --
--
ende